Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Use of liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in neoadjuvant pancreatic adenocarcinoma: NEO-Nal-IRI trial.
Journal: The oncologist
Published: February 09, 2026
Dynasore as a dual modulator of lipid rafts and cell death in pancreatic cancer.
Journal: Neoplasia (New York, N.Y.)
Published: August 31, 2025
Multifaceted effects of the microbiome in pancreatic cancer: from association to modulation.
Journal: Nature reviews. Gastroenterology & hepatology
Published: August 22, 2025
Microbial molecules, metabolites, and malignancy.
Journal: Neoplasia (New York, N.Y.)
Published: September 02, 2024
A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma.
Journal: Future oncology (London, England)
Published: September 27, 2023
Role of Bacteria in the Development of Colorectal Cancer.
Journal: Clinics in colon and rectal surgery
Published: February 27, 2023
Maestros of malignancy: Microbes as the conductors of carcinogenesis.
Journal: Neoplasia (New York, N.Y.)
Published: February 07, 2023
Atezolizumab plus tivozanib for immunologically cold tumor types: the IMMCO-1 trial.
Journal: Future oncology (London, England)
Published: November 18, 2022
The Influence of the microbiome on the innate immune microenvironment of solid tumors.
Journal: Neoplasia (New York, N.Y.)
Published: October 27, 2022
Association of Medical Appointment Cancellation Rates on Survival After Esophagectomy for Esophageal Cancer.
Journal: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
Published: May 20, 2022
Last Updated: 09/26/2026